Auscann Group Holdings Share Price and Company Fundamentals



Price
$0.1
Change
-0.005 (-4.762%)
52 week
0.093 - 0.3

Last traded: Yesterday at 6:10 AM

AusCann Group Holdings Ltd, a pharmaceutical company, researches, develops, cultivates, produces, and distributes cannabinoid-based pharmaceuticals in Australia and internationally. It offers hard-shell capsules using Neuvis technology for the treatment of chronic neuropathic pain. The company is based in West Perth, Australia.

Key Metrics

PE ratio

-

PB ratio

1.05

Dividend yield

Beta

1.48

Market cap

$44.05M

Enterprise value

$17.84M

Company profile

Primary activitiesCultivation, manufacture and supply of medical cannabis products.
Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Websitehttp://auscann.com.au
Mailing address35 Havelock Street Level 5 West Perth WA 6005 Australia
Phone / Fax61 8 6305 0705 / 61 8 6255 5031
Share registryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED

Dividends

Auscann Group Holdings does not pay dividends.

Company Executives

As of Aug 2021, following are the company executives and directors listed on Auscann Group Holdings.

NameTitleAgeTotal Pay
Mr. Layton Patrick MillsChief Exec. Officer
Mr. Charles AltshulerCFO & Head of Supply
Ms. Susan Patricia Park B.Com., FCIS, A.C.A., M.A.I.C.D., A.C.I.S., BComJoint Company Sec.45

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-635.04%

Return on assets

-14.30%

Return on equity

-24.10%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Auscann Group Holdings is 44.05M and its enterprise value is 17.84M. The enterprise value to revenue ratio of AC8 is 14.07.

The AC8's stocks Beta value is 1.48 making it 48% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Auscann Group Holdings (AC8)

Auscann Group Holdings (ASX:AC8) Frequently Asked Questions

1. What is Auscann Group Holdings's Stock Symbol?

Auscann Group Holdings trades on ASX under the ticker symbol "AC8".

2. What is Auscann Group Holdings's stock price today?

One share of AC8 stock can currently be purchased for approximately $0.1.

3. How can I contact Auscann Group Holdings?

Auscann Group Holdings's mailing address is 35 Havelock Street Level 5 West Perth WA 6005 Australia. The company can be reached via phone at 61 8 6305 0705.

4. What is Auscann Group Holdings's official website?

The official website of Auscann Group Holdings is http://auscann.com.au.

5. Which share registry manages Auscann Group Holdings's stock?

Auscann Group Holdings's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.